Matt Larson has over a decade of experience in the ophthalmic sector. With roles on the clinical research side as well as several positions with a commercial focus, Matt has been involved in multiple aspects of medical device companies. He was responsible for launching the KAMRA corneal inlay in Asia Pacific, and while living in Tokyo, Japan he brought this innovative device for the treatment of presbyopia to over a dozen countries in the Asia Pacific region. He led the launch of the IC-8 intraocular lens in Europe and Asian Pacific. Matt also played an executive role in getting US approval for the KAMRA corneal inlay–the first corneal inlay for presbyopia approved in the U.S. He is currently the President and COO of Equinox Ophthalmic, Inc. which is a company developing a novel medical device for the treatment of glaucoma. He is a graduate of the University of California, Santa Barbara.